KRAS and colorectal cancer: Nevertheless, several works performed on M229 R5, M238 R1 and M14 melanoma cells and on Ki-Ras-mutated colorectal cancer cell lines show that these cells are able to acquire the resistance to MEK/ERK suppression [59].